Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV001288900 | SCV001476306 | benign | not specified | 2019-12-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002069556 | SCV002375398 | benign | not provided | 2023-10-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004035564 | SCV004990248 | uncertain significance | Inborn genetic diseases | 2021-09-16 | criteria provided, single submitter | clinical testing | The c.815C>T (p.T272M) alteration is located in exon 6 (coding exon 6) of the NOTCH3 gene. This alteration results from a C to T substitution at nucleotide position 815, causing the threonine (T) at amino acid position 272 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Gene |
RCV002069556 | SCV005396097 | uncertain significance | not provided | 2024-05-08 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 34589931) |
Prevention |
RCV004738227 | SCV005349858 | likely benign | NOTCH3-related disorder | 2024-09-11 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |